医学
一氧化氮
安慰剂
双盲
肺病
肺
随机对照试验
内科学
麻醉
病理
替代医学
作者
Steven D. Nathan,Natasa Rajicic,Rosemarie Beckford Dudenhofer,Rahat Hussain,Rahul Argula,Debabrata Bandyopadhyay,Tracy Luckhardt,Natalia Muehlemann,Kevin R. Flaherty,Marilyn K. Glassberg,Lisa Lancaster,Ganesh Raghu,Peter Fernandes
出处
期刊:Annals of the American Thoracic Society
[American Thoracic Society]
日期:2024-08-14
卷期号:21 (12): 1661-1669
被引量:2
标识
DOI:10.1513/annalsats.202406-662oc
摘要
Inhaled nitric oxide (iNO) has been shown to result in benefits in moderate to vigorous physical activity (MVPA) in patients with fibrotic interstitial lung disease (f-ILD) receiving supplemental oxygen in two independent trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI